mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.2 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.2 |
mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
Mdivi-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.2 |
mRNA |
BRD-K90370028 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.2 |
mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.2 |